We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$14.9B
AUM Growth
+$995M
(+7.2%)
Cap. Flow
-$291M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
26.38%
Holding
2,856
New
31
Increased
336
Reduced
1,500
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$128M |
| 2 |
LTHM
Livent Corporation
LTHM
|
+$15M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$12.3M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$12.2M |
| 5 |
P
Everpure Inc
P
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$28.4M |
| 2 |
Microsoft
MSFT
|
+$25.6M |
| 3 |
NVIDIA
NVDA
|
+$15.2M |
| 4 |
Amazon
AMZN
|
+$11.2M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.53% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 11.68% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Xponential Fitness
XPOF
$206M
| $219K | ﹤0.01% |
13,260
| – | – |
|
2152
Aviat Networks
AVNW
$282M
| $219K | ﹤0.01% |
5,718
| – | – |
|
2153
Allogene Therapeutics
ALLO
$683M
| $219K | ﹤0.01% |
49,000
+6,982
| +17% | +$29.1K |
|
2154
Movado Group
MOV
$796M
| $219K | ﹤0.01% |
7,842
| – | – |
|
|
SHYF
2155
DELISTED
The Shyft Group
SHYF
| $219K | ﹤0.01% |
17,635
| – | – |
|
2156
Avita Medical
RCEL
$248M
| $219K | ﹤0.01% |
13,645
| – | – |
|
|
FARO
2157
DELISTED
Faro Technologies
FARO
| $219K | ﹤0.01% |
10,168
| – | – |
|
2158
BRC Group Holdings
RILY
$303M
| $218K | ﹤0.01% |
10,318
| – | – |
|
2159
Evolv Technologies
EVLV
$1.04B
| $218K | ﹤0.01% |
49,014
-11,366
| -19% | -$49.1K |
|
2160
Replimune Group
REPL
$1.42B
| $218K | ﹤0.01% |
26,645
| – | – |
|
2161
SIGA Technologies
SIGA
$207M
| $217K | ﹤0.01% |
25,369
-3,192
| -11% | -$18.2K |
|
2162
Enliven Therapeutics
ELVN
$4.25B
| $217K | ﹤0.01% |
12,345
| – | – |
|
2163
Liquidity Services
LQDT
$1.35B
| $217K | ﹤0.01% |
11,662
| – | – |
|
2164
Invesco Mortgage Capital
IVR
$805M
| $216K | ﹤0.01% |
22,326
| – | – |
|
2165
CNB Financial Corp
CCNE
$1.04B
| $216K | ﹤0.01% |
10,574
| – | – |
|
2166
Opko Health
OPK
$1.04B
| $216K | ﹤0.01% |
179,588
-31,760
| -15% | -$31.8K |
|
2167
Shift4
FOUR
$3.79B
| $215K | ﹤0.01% |
3,260
+10
| +0.3% | +$752 |
|
2168
Adtran
ADTN
$658M
| $215K | ﹤0.01% |
39,528
-441
| -1% | -$2.81K |
|
2169
Bar Harbor Bankshares
BHB
$681M
| $214K | ﹤0.01% |
8,070
| – | – |
|
2170
FRP Holdings
FRPH
$425M
| $213K | ﹤0.01% |
6,950
| – | – |
|
2171
Medifast
MED
$128M
| $213K | ﹤0.01% |
5,560
| – | – |
|
2172
BrightView Holdings
BV
$1.08B
| $213K | ﹤0.01% |
17,885
-4,023
| -18% | -$36.6K |
|
2173
Alerus Financial
ALRS
$844M
| $212K | ﹤0.01% |
9,726
| – | – |
|
2174
America's Car Mart
CRMT
$25.7M
| $212K | ﹤0.01% |
3,322
| – | – |
|
2175
TechnipFMC
FTI
$30.1B
| $212K | ﹤0.01% |
8,443
+19
| +0.2% | +$400 |
|
Similar funds
PCM
HHII
EIM
P
BPA
NAM
MIC
MetLife Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, MetLife Investment Management held 2,856 positions worth $14.9B, up 7.2% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.6%. MetLife Investment Management opened 31 new positions and exited 71, leaving the 2,856-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- MetLife Investment Management's largest Q1 2024 buy was Flutter Entertainment: 9,898 shares worth $1.98M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $128M increase.
- MetLife Investment Management's biggest Q1 2024 reduction was Apple, cutting an estimated $28.4M.
- MetLife Investment Management fully exited Immunogen Inc in Q1 2024, selling an estimated $3.72M.
- MetLife Investment Management's ten largest holdings make up 26% of its $14.9B portfolio in Q1 2024.
- MetLife Investment Management opened 31 new positions and closed 71 in Q1 2024.
- MetLife Investment Management's portfolio value rose 7.2% quarter-over-quarter to $14.9B.
Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.